Views & Analysis GSK and Sanofi CEOs: it's drug prices, stupid How pharma can move on from the recent controversies around pricing is one of the industry's biggest issues.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
